The polymicrobial nature of airway infections in cystic fibrosis: Cangene gold medal lecture

Canadian Journal of Microbiology

Volumn 57, Issue 2, 2011, Pages 69-77

  Sibley, Christopher D ^a   Surette, Michael G ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cystic fibrosis; Microbial communities; Polymicrobial

Indexed keywords

BACTERIAL PATHOGENS; CYSTIC FIBROSIS; EMERGENT PROPERTY; FUTURE CHALLENGES; HUMAN BODIES; LUNG DISEASE; MICROBIAL COMMUNITIES; POLYMICROBIAL;

MICROORGANISMS;

ANTIBIOTIC AGENT; RNA 16S; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BACTERIUM; INFECTIVITY; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; PATHOGEN;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASPERGILLUS; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BURKHOLDERIA CEPACIA; COLONY FORMING UNIT; CYSTIC FIBROSIS; DROSOPHILA MELANOGASTER; GENOTYPE; HAEMOPHILUS INFLUENZAE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; MICROBIOME; MOLECULAR PATHOLOGY; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RALSTONIA; RESPIRATORY TRACT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SPUTUM; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MILLERI;

ANIMALS; BACTERIA; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; METAGENOME; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS);

EID: 79953112436     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W10-105     Document Type: Review

References (71)

1. Aaron, S.D., Vandemheen, K.L., Ferris, W., Fergusson, D., Tullis, E., Haase, D., et al. 2005. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Lancet, 366(9484): 463-471. doi:10.1016/S0140-6736(05)67060-2. PMID:16084254.
2. Bakaletz, L.O. 2004. Developing animal models for polymicrobial diseases. Nat. Rev. Microbiol. 2(7): 552-568. doi:10.1038/nrmicro928. PMID:15197391.
3. Boucher, R.C. 2007. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu. Rev. Med. 58(1): 157-170. doi:10.1146/annurev.med.58.071905.105316. PMID:17217330.
4. Brogden, K.A., and Guthmiller, J.M. 2003. Polymicrobial diseases, a concept whose time has come. ASM News, 69: 69-73.
5. Brogden, K.A., Guthmiller, J.M., and Taylor, C.E. 2005. Human polymicrobial infections. Lancet, 365(9455): 253-255. PMID: 15652608.
6. Brook, I., and Fink, R. 1983. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis. Eur. J. Respir. Dis. 64(1): 51-57. PMID:6825749.
7. Chugani, S.A., Whiteley, M., Lee, K.M., D'Argenio, D., Manoil, C., and Greenberg, E.P. 2001. QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aerugi-nosa. Proc. Natl. Acad. Sci. U.S.A. 98(5): 2752-2757. doi:10. 1073/pnas.051624298. PMID:11226312.
8. Davis, P.B., Drumm, M., and Konstan, M.W. 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154(5): 1229-1256. PMID: 8912731.
9. Donachie, S.P., Hou, S., Lee, K.S., Riley, C.W., Pikina, A., Belisle, C., et al. 2004. The Hawaiian Archipelago: a microbial diversity hotspot. Microb. Ecol. 48(4): 509-520. doi:10.1007/s00248-004-0217-1. PMID:15696384.
10. Donachie, S.P., Foster, J.S., and Brown, M.V. 2007. Culture clash: challenging the dogma of microbial diversity. ISME J. 1(2): 97-99. doi:10.1038/ismej.2007.22. PMID:18043618.
11. Duan, K., Dammel, C., Stein, J., Rabin, H., and Surette, M.G. 2003. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol. Microbiol. 50(5): 1477-1491. doi:10.1046/j.1365-2958.2003. 03803.x. PMID:14651632.
12. Eilers, H., Pernthaler, J., Glöckner, F.O., and Amann, R. 2000. Cul-turability and in situ abundance of pelagic bacteria from the North Sea. Appl. Environ. Microbiol. 66(7): 3044-3051. doi:10. 1128/AEM.66.7.3044-3051.2000. PMID:10877804.
13. Erickson, D.L., Lines, J.L., Pesci, E.C., Venturi, V., and Storey, D.G. 2004. Pseudomonas aeruginosa relA contributes to virulence in Drosophila melanogaster. Infect. Immun. 72(10): 5638-5645. doi:10.1128/IAI.72.10.5638-5645.2004. PMID: 15385461.
14. Field, T.R., Sibley, C.D., Parkins, M.D., Rabin, H.R., and Surette, M.G. 2010. The genus Prevotella in cystic fibrosis airways. Anaerobe, 16(4): 337-344. doi:10.1016/j.anaerobe.2010.04.002. PMID:20412865.
15. Foweraker, J. 2009. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br. Med. Bull. 89(1): 93-110. doi:10.1093/bmb/ldn050. PMID:19155262.
16. Gibson, R.L., Burns, J.L., and Ramsey, B.W. 2003. Pathophysiol-ogy and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168(8): 918-951. doi:10.1164/rccm.200304-505SO. PMID:14555458.
17. Gilligan, P.H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4(1): 35-51. PMID: 1900735.
18. Gilligan, P.H., and Kiska, D.L. 2006. Cumitech: cystic fibrosis microbiology. American Society of Microbiology.
19. Grinwis, M.E., Sibley, C.D., Parkins, M.D., Eshaghurshan, C.S., Rabin, H.R., and Surette, M.G. 2010a. Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis. J. Clin. Microbiol. 48(2): 395-401. doi:10.1128/JCM.01807-09. PMID:20007382.
20. Grinwis, M.E., Sibley, C.D., Parkins, M.D., Eshaghurshan, C.S., Rabin, H.R., and Surette, M.G. 2010b. Macrolide and clindamy-cin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. Antimicrob. Agents Che-mother. 54(7): 2823-2829. doi:10.1128/AAC.01845-09. PMID: 20404127.
21. Harris, J.K., De Groote, M.A., Sagel, S.D., Zemanick, E.T., Kaps-ner, R., Penvari, C., et al. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 104(51): 20 529-20 533. doi:10.1073/pnas.0709804104. PMID:18077362.
22. Harrison, F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology, 153(4): 917-923. doi:10.1099/mic.0.2006/004077-0. PMID:17379702.
23. Ishikuri, S., and Hattori, T. 1985. Formation of bacterial colonies in successive time intervals. Appl. Environ. Microbiol. 49(4): 870-873. PMID:4004219.
24. Jewes, L.A., and Spencer, R.C. 1990. The incidence of anaerobes in the sputum of patients with cystic fibrosis. J. Med. Microbiol. 31(4): 271-274. doi:10.1099/00222615-31-4-271. PMID: 2325116.
25. Kaeberlein, T., Lewis, K., and Epstein, S.S. 2002. Isolating "uncul-tivable" microorganisms in pure culture in a simulated natural environment. Science, 296(5570): 1127-1129. doi:10.1126/science.1070633. PMID:12004133.
26. Kaiser, O., Pühler, A., and Selbitschka, W. 2001. Phylogenetic analysis of microbial diversity in the rhizoplane of oilseed rape (Brassica napus cv. Westar) employing cultivation-dependent and cultivation-independent approaches. Microb. Ecol. 42(2): 136-149. PMID:12024277.
27. Kligler, I.J. 1915. A biochemical study and differentiation of oral bacteria with special reference to dental caries. II. Experimental. J. Allied Dent. Soc. 10: 282-330.
28. Köpke, B., Wilms, R., Engelen, B., Cypionka, H., and Sass, H. 2005. Microbial diversity in coastal subsurface sediments: a cultivation approach using various electron acceptors and substrate gradients. Appl. Environ. Microbiol. 71(12): 7819-7830. doi:10. 1128/AEM.71.12.7819-7830.2005. PMID:16332756.
29. Kukavica-Ibrulj, I., and Levesque, R.C. 2008. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab. Anim. 42(4): 389-412. doi:10.1258/la.2007.06014e. PMID:18782827.
30. Lewis, P.A., and Shope, R.E. 1931. Swine influenza: II. A hemo-philic bacillus from the respiratory tract of infected swine. J. Exp. Med. 54(3): 361-371. doi:10.1084/jem.54.3.361. PMID: 19869923.
31. Liou, T.G., Adler, F.R., Fitzsimmons, S.C., Cahill, B.C., Hibbs, J.R., and Marshall, B.C. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol. 153(4): 345-352. doi:10.1093/aje/153.4.345. PMID:11207152.
32. LiPuma, J.J. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23(2): 299-323. doi:10.1128/CMR.00068-09. PMID:20375354.
33. Lutter, E.I., Faria, M.M., Rabin, H.R., and Storey, D.G. 2008. Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models. Infect. Immun. 76(5): 1877-1888. doi:10.1128/IAI.01165-07. PMID:18285499.
34. Manganiello, A.D., Socransky, S.S., Smith, C., Propas, D., Oram, V., and Dogon, I.L. 1977. Attempts to increase viable count recovery of human supragingival dental plaque. J. Periodontal Res. 12(2): 107-119. doi:10.1111/j.1600-0765.1977.tb00113.x. PMID:138728.
35. Matsui, H., Grubb, B.R., Tarran, R., Randell, S.H., Gatzy, J.T., Davis, C.W., and Boucher, R.C. 1998. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell, 95(7): 1005-1015. doi:10.1016/S0092-8674(00)81724-9. PMID: 9875854.
36. Maturrano, L., Santos, F., Rosselló-Mora, R., and Antón, J. 2006. Microbial diversity in Maras salterns, a hypersaline environment in the Peruvian Andes. Appl. Environ. Microbiol. 72(6): 3887-3895. doi:10.1128/AEM.02214-05. PMID:16751493.
37. Munson, M.A., Pitt-Ford, T., Chong, B., Weightman, A., and Wade, W.G. 2002. Molecular and cultural analysis of the micro-flora associated with endodontic infections. J. Dent. Res. 81(11): 761-766. doi:10.1177/154405910208101108. PMID:12407091.
38. Munson, M.A., Banerjee, A., Watson, T.F., and Wade, W.G. 2004. Molecular analysis of the microflora associated with dental caries. J. Clin. Microbiol. 42(7): 3023-3029. doi:10.1128/JCM.42. 7.3023-3029.2004. PMID:15243054.
39. O'Sullivan, B.P., and Freedman, S.D. 2009. Cystic fibrosis. Lancet, 373(9678): 1891-1904. doi:10.1016/S0140-6736(09)60327-5. PMID:19403164.
40. Parkins, M.D., Sibley, C.D., Surette, M.G., and Rabin, H.R. 2008a. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr. Pulmonol. 43(5): 490-497. doi:10.1002/ppul.20809. PMID:18383109.
41. Parkins, M.D., Sibley, C.D., Surette, M.G., Gregson, D.B., and Rabin, H.R. 2008b. Streptococcus milleri endobronchial colonization is associated with an increased rate of pulmonary disease progression in cystic fibrosis. Pediatr. Pulmonol. Suppl. 31, 339.
42. Ramsey, B.W. 1996. Management of pulmonary disease in patients with cystic fibrosis. N. Engl. J. Med. 335(3): 179-188. doi:10. 1056/NEJM199607183350307. PMID:8657217.
43. Rivers, T.M. 1937. Viruses and Koch's postulates. J. Bacteriol. 33(1): 1-12. PMID:16559982.
44. Rogers, G.B., Hart, C.A., Mason, J.R., Hughes, M., Walshaw, M.J., and Bruce, K.D. 2003. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 41(8): 3548-3558. doi:10.1128/JCM.41.8.3548-3558.2003. PMID:12904354.
45. Rogers, G.B., Carroll, M.P., Serisier, D.J., Hockey, P.M., Jones, G., and Bruce, K.D. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S riboso-mal DNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 42(11): 5176-5183. doi:10.1128/JCM.42.11.5176-5183.2004. PMID:15528712.
46. Rogers, G.B., Daniels, T.W., Tuck, A., Carroll, M.P., Connett, G.J., David, G.J., and Bruce, K.D. 2009. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches. BMC Pulm. Med. 9(1): 14. doi:10.1186/1471-2466-9-14. PMID:19368727.
47. Ruoff, K.L. 1988. Streptococcus anginosus ("Streptococcus mill-eri"): the unrecognized pathogen. Clin. Microbiol. Rev. 1(1): 102-108. PMID:3060239.
48. Sanders, D.B., Bittner, R.C., Rosenfeld, M., Hoffman, L.R., Redding, G.J., and Goss, C.H. 2010a. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 182(5): 627-632. doi:10.1164/rccm.200909-1421OC. PMID:20463179.
49. Sanders, D.B., Hoffman, L.R., Emerson, J., Gibson, R.L., Rosen-feld, M., Redding, G.J., and Goss, C.H. 2010b. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pe-diatr. Pulmonol. 45(2): 127-134. doi:10.1002/ppul.21117. PMID:20054859.
50. Shawkey, M.D., Mills, K.L., Dale, C., and Hill, G.E. 2005. Micro-bial diversity of wild bird feathers revealed through culture-based and culture-independent techniques. Microb. Ecol. 50(1): 40-47. doi:10.1007/s00248-004-0089-4. PMID:16132422.
51. Shinzato, T., and Saito, A. 1995. The Streptococcus milleri group as a cause of pulmonary infections. Clin. Infect. Dis. 21(Suppl 3): S238-S243. PMID:8749672.
52. Shope, R.E. 1931a. Swine influenza: I. Experimental transmission and pathology. J. Exp. Med. 54(3): 349-359. doi:10.1084/jem. 54.3.349. PMID:19869922.
53. Shope, R.E. 1931b. Swine influenza: III. Filtration experiments and etiology. J. Exp. Med. 54(3): 373-385. doi:10.1084/jem.54.3. 373. PMID:19869924.
54. Sibley, C.D., Rabin, H., and Surette, M.G. 2006. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol. 1(1): 53-61. doi:10.2217/17460913.1.1.53. PMID:17661685.
55. Sibley, C.D., Duan, K., Fischer, C., Parkins, M.D., Storey, D.G., Rabin, H.R., et al. 2008a. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog. 4(10): e1000184. doi:10.1371/journal. ppat.1000184. PMID:18949036.
56. Sibley, C.D., Parkins, M.D., Rabin, H.R., Duan, K., Norgaard, J.C., and Surette, M.G. 2008b. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fi-brosis patients. Proc. Natl. Acad. Sci. U.S.A. 105(39): 15 070-15 075. doi:10.1073/pnas.0804326105. PMID:18812504.
57. Sibley, C.D., Parkins, M.D., Rabin, H.R., and Surette, M.G. 2009. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibro-sis. Curr. Opin. Investig. Drugs, 10(8): 787-794. PMID: 19649923.
58. Sibley, C.D., Grinwis, M.E., Field, T.R., Parkins, M.D., Norgaard, J.C., Gregson, D.B., et al. 2010a. McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fi-brosis patients. J. Med. Microbiol. 59(5): 534-540. doi:10.1099/jmm.0.016592-0. PMID:20093379.
59. Sibley, C.D., Sibley, K.A., Leong, T.A., Grinwis, M.E., Parkins, M.D., Rabin, H.R., and Surette, M.G. 2010b. The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J. Clin. Microbiol. 48(7): 2592-2594. doi:10.1128/JCM.00414-10. PMID:20463160.
60. Smith, H. 1982. The role of microbial interactions in infectious disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 297(1088): 551-561. doi:10.1098/rstb.1982.0060. PMID:6125962.
61. Smith, E.E., Buckley, D.G., Wu, Z., Saenphimmachak, C., Hoffman, L.R., D'Argenio, D.A., et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U.S.A. 103(22): 8487-8492. doi:10.1073/pnas.0602138103. PMID:16687478.
62. Staley, J.T., and Konopka, A. 1985. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 39(1): 321-346. doi:10. 1146/annurev.mi.39.100185.001541. PMID:3904603.
63. Stoltz, D.A., Meyerholz, D.K., Pezzulo, A.A., Ramachandran, S., Rogan, M.P., Davis, G.J., et al. 2010. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med, 2(29): ra31. PMID:20427821.
64. Thompson, J.R., Pacocha, S., Pharino, C., Klepac-Ceraj, V., Hunt, D.E., Benoit, J., et al. 2005. Genotypic diversity within a natural coastal bacterioplankton population. Science, 307(5713): 1311-1313. doi:10.1126/science.1106028. PMID:15731455.
65. Tunney, M.M., Field, T.R., Moriarty, T.F., Patrick, S., Doering, G., Muhlebach, M.S., et al. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177(9): 995-1001. doi:10.1164/rccm. 200708-1151OC. PMID:18263800.
66. Turnbaugh, P.J., Quince, C., Faith, J.J., McHardy, A.C., Yatsu-nenko, T., Niazi, F., et al. 2010. Organismal, genetic, and tran-scriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc. Natl. Acad. Sci. U.S.A. 107(16): 7503-7508. doi:10.1073/pnas.1002355107. PMID:20363958.
67. Venter, J.C. 2010. Multiple personal genomes await. Nature, 464(7289): 676-677. doi:10.1038/464676a. PMID:20360717.
68. Watve, M., Shejval, V., Sonawane, C., Rahalkar, M., Matapurkar, A., Shouche, Y., et al. 2000. The 'K' selected oligophilic bacteria: A key to uncultured diversity? Curr. Sci. India, 78(12): 1535-1542.
69. Winding, A., Binnerup, S.J., and Sørensen, J. 1994. Viability of indigenous soil bacteria assayed by respiratory activity and growth. Appl. Environ. Microbiol. 60(8): 2869-2875. PMID: 16349355.
70. Worlitzsch, D., Rintelen, C., Böhm, K., Wollschläger, B., Merkel, N., Borneff-Lipp, M., and Döring, G. 2009. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin. Microbiol. Infect. 15(5): 454-460. doi:10.1111/j. 1469-0691.2008.02659.x. PMID:19196263.
71. Zengler, K. 2009. Central role of the cell in microbial ecology. Microbiol. Mol. Biol. Rev. 73(4): 712-729. doi:10.1128/MMBR.00027-09. PMID:19946138.